131 related articles for article (PubMed ID: 29372493)
1. The predictive potential of hyponatremia for glioblastoma patient survival.
Mrowczynski OD; Bourcier AJ; Liao J; Langan ST; Specht CS; Rizk EB
J Neurooncol; 2018 May; 138(1):99-104. PubMed ID: 29372493
[TBL] [Abstract][Full Text] [Related]
2. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
Ochiai H; Uenishi E
Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
[TBL] [Abstract][Full Text] [Related]
3. Hyponatremia in pulmonary TB: evidence of ectopic antidiuretic hormone production.
Lee P; Ho KK
Chest; 2010 Jan; 137(1):207-8. PubMed ID: 20051406
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
MacMillan TE; Cavalcanti RB
Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
[TBL] [Abstract][Full Text] [Related]
5. The Potential of Glioblastoma Patient Symptoms to Diagnose and Predict Survival.
Mrowczynski OD; Yang AL; Liao J; Rizk E
Cureus; 2021 Jul; 13(7):e16675. PubMed ID: 34462698
[TBL] [Abstract][Full Text] [Related]
6. The productions of atrial natriuretic peptide and arginine vasopressin in small cell lung cancer with brain metastases and their associations with hyponatremia.
Sun NH; Wang SH; Liu JN; Liu A; Gong WJ; Liu Y; Sun P; Li H
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4104-4112. PubMed ID: 29028089
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative Use of Desmopressin for Treatment of Profound Hyponatremia in the Setting of Emergency Surgery: A Case Report.
Watterworth BS; Noorani RJ
A A Pract; 2018 Jul; 11(2):54-56. PubMed ID: 29634545
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
MacMillan TE; Tang T; Cavalcanti RB
Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
[TBL] [Abstract][Full Text] [Related]
9. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
Choi EY; Park JS; Kim YT; Park SY; Kim GH
Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
[TBL] [Abstract][Full Text] [Related]
10. Experience with electrolyte levels after craniotomy for pediatric brain tumors.
Madden JR; Dobyns E; Handler M; Foreman NK
J Pediatr Oncol Nurs; 2010; 27(1):21-3. PubMed ID: 19687467
[TBL] [Abstract][Full Text] [Related]
11. O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma.
Sonoda Y; Yokosawa M; Saito R; Kanamori M; Yamashita Y; Kumabe T; Watanabe M; Tominaga T
Int J Clin Oncol; 2010 Aug; 15(4):352-8. PubMed ID: 20232102
[TBL] [Abstract][Full Text] [Related]
12. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival.
Chaurasia A; Park SH; Seo JW; Park CK
J Korean Med Sci; 2016 Aug; 31(8):1208-14. PubMed ID: 27478330
[TBL] [Abstract][Full Text] [Related]
14. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
15. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
[TBL] [Abstract][Full Text] [Related]
16. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Kazama I; Hatano R; Michimata M; Suzuki K; Arata T; Suzuki M; Miyama N; Sato A; Satomi S; Ejima Y; Sasaki S; Matsubara M
Kidney Int; 2005 May; 67(5):1855-67. PubMed ID: 15840033
[TBL] [Abstract][Full Text] [Related]
17. Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma.
Shin JY; Kizilbash SH; Robinson S; Uhm JH; Jatoi A
Am J Hosp Palliat Care; 2017 Aug; 34(7):650-653. PubMed ID: 27151973
[TBL] [Abstract][Full Text] [Related]
18. The Impact of a Standardized Sodium Protocol on Incidence and Outcome of Dysnatremias in Neurocritical Care.
Spatenkova V; Bradac O; Skrabalek P
J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):279-90. PubMed ID: 25539069
[TBL] [Abstract][Full Text] [Related]
19. Semantic imaging features predict disease progression and survival in glioblastoma multiforme patients.
Peeken JC; Hesse J; Haller B; Kessel KA; Nüsslin F; Combs SE
Strahlenther Onkol; 2018 Jun; 194(6):580-590. PubMed ID: 29442128
[TBL] [Abstract][Full Text] [Related]
20. Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.
Schiffgens S; Wilkens L; Brandes AA; Meier T; Franceschi E; Ermani M; Hartmann C; Sandalcioglu IE; Dumitru CA
Oncotarget; 2016 Aug; 7(34):55169-55180. PubMed ID: 27409829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
